New targeted therapies for genetically linked skin diseases

Tuberous Sclerosis Topical Rapamycin could be used to treat facial angiofibromas (“Adenoma Sebaceum”) (link) (Archives of Dermatology, 2010) Neurofibromatosis (Recklinghausen’s Disease) Mast cells play an important role The c-Kit receptor on mast cells is stimulated by mediators that are liberated by Schwann cells The activation of mast cells then induces the liberation of maediators that […]

Tags: Basal Cell Carcinoma (BCC), Carcinome Basocellulaire (CBC), CHILD syndrome, Epidermolyse Bulleuse Dystrophique Récessive, Epidermolyse Bulleuse Simple (Simplex) (EBS), Epidermolysis Bullosa Simplex (EBS), Neurofibromatose (Maladie de Recklinghausen), Neurofibromatosis (Recklinghausen's Disease), New targeted therapies for genetically linked skin diseases, Nouvelles thérapies ciblées pour le traitement de maladies de la peau avec des anomalies génétiques, progeria, Recessive Dystrophic Epidermolysis Bullosa (EB), Sclérose Tubéreuse de Bourneville, Syndrome de CHILD, Tuberous Sclerosis
Posted in Conference Notes |